echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Blood System > J Hematol Oncol: The response of multiple myeloma patients to COVID-19 mRNA vaccination is conservative but impaired

    J Hematol Oncol: The response of multiple myeloma patients to COVID-19 mRNA vaccination is conservative but impaired

    • Last Update: 2021-11-03
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    Multiple myeloma patients are high- risk patients with severe COVID-19 .


    COVID-19

     

     

    Compared with the control group, the anti-spinous IgG levels of multiple myeloma patients decreased, but the proportion of patients who achieved a humoral response was high (89% vs 97%, the control group)


    Overall, these results support that the response of MM patients to the two doses of anti-SARS CoV 2 BNT162b2 vaccine is lower than that of HC


    Immunity


    Original source:

    Bitoun, S.


    Bitoun, S.
    , Henry, J.
    , Vauloup-Fellous, C.
    et al.
    Response to COVID-19 mRNA vaccination in multiple myeloma is conserved but impaired compared to controls.
    J Hematol Oncol 14,166 (2021).
    https:/ /doi.
    org/10.
    1186/s13045-021-01183-2 Leave a message here

    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.